RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Atreca Stock

Atreca Net Income 2024

Atreca Net Income

-26.29 M USD

Ticker

BCEL

ISIN

US04965G1094

WKN

A2PLNM

In 2024, Atreca's profit amounted to -26.29 M USD, a -68.14% increase from the -82.5 M USD profit recorded in the previous year.

The Atreca Net Income history

YEARNET INCOME (undefined USD)
2029e-
2028e-
2027e-
2026e-
2025e-
2024e-
2023e-
2022-
2021-
2020-
2019-
2018-
2017-

Atreca Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Atreca, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Atreca from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Atreca’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Atreca. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Atreca’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Atreca’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Atreca’s growth potential.

Atreca Revenue, EBIT and net profit per share

DateAtreca RevenueAtreca EBITAtreca Net Income
2029e0 undefined0 undefined0 undefined
2028e0 undefined-70.38 M undefined-51.36 M undefined
2027e0 undefined-59.16 M undefined-43.68 M undefined
2026e0 undefined-59.05 M undefined-41.25 M undefined
2025e0 undefined-49.98 M undefined-30.33 M undefined
2024e0 undefined-40.29 M undefined-26.29 M undefined
2023e0 undefined-83.49 M undefined-82.5 M undefined
20220 undefined-98.29 M undefined-97.16 M undefined
20210 undefined-110.3 M undefined-109.33 M undefined
20200 undefined-88.88 M undefined-86.34 M undefined
20190 undefined-72.57 M undefined-67.48 M undefined
20180 undefined-39.57 M undefined-37.94 M undefined
20170 undefined-29.44 M undefined-27.53 M undefined

Atreca stock margins

The Atreca margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Atreca. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Atreca.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Atreca's sales revenue. A higher gross margin percentage indicates that the Atreca retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Atreca's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Atreca's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Atreca's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Atreca. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Atreca's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Atreca Margin History

Atreca Gross marginAtreca Profit marginAtreca EBIT marginAtreca Profit margin
2029e0 %0 %0 %
2028e0 %0 %0 %
2027e0 %0 %0 %
2026e0 %0 %0 %
2025e0 %0 %0 %
2024e0 %0 %0 %
2023e0 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %

Atreca Aktienanalyse

What does Atreca do?

Atreca Inc is a biotechnology company that specializes in researching and developing novel immunotherapies for various diseases. It was founded in 2010 by a team of renowned scientists who share a common passion for discovering innovative approaches to treating serious illnesses. The company's business model is based on the identification of antigens - biological molecules that the immune system recognizes and responds to - from the cells of patients suffering from severe diseases such as cancer or autoimmune disorders. Atreca utilizes its proprietary technology platform, called Immune Repertoire Capture (IRC) technology, to isolate and identify these antigens. Once identified, the company can use these antigens to develop new immunotherapies that activate the patient's immune system to fight the disease. These personalized immunotherapies have the potential to be more specific and effective than conventional approaches used on a broad basis. Atreca has split into two main areas to optimize its business model: monetizing research and development and making its technology platform accessible to other companies. The company's research and development department focuses on the discovery and development of personalized immunotherapies for various types of cancer and autoimmune disorders. The company recently entered into a significant milestone agreement with a subsidiary of Merck to develop personalized immunotherapies for selected types of cancer. Atreca also has a separate business unit that provides its IRC technology to other companies. This business unit offers contract research and consulting services to assist other biotechnology and pharmaceutical clients in the identification of antigens and the development of personalized immunotherapies. By providing IRC technology to other companies, Atreca has tapped into a new revenue stream that allows it to offer unique and effective biotechnology solutions in the future. In terms of its products, Atreca has several potential immunotherapy candidates in its pipeline, some of which are already being tested in clinical trials. One of its key products is a personalized immunotherapy drug called ATRC-101, which targets the treatment of patients with metastatic solid tumors. The drug utilizes Atreca's IRC technology to identify the antigens in the patients and develop personalized immunotherapies based on these antigens. Furthermore, the company has additional drug candidates in the development phase and is also considering the possibility of venturing into other disease areas such as infectious diseases. Atreca has the potential to become a key player in the biotechnology industry by providing personalized and effective immunotherapies for a variety of diseases. Atreca ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Atreca's Profit Margins

The profit margins of Atreca represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Atreca's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Atreca's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Atreca's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Atreca’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Atreca stock

How much profit has Atreca made this year?

Atreca has made -26.29 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -68.14% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Atreca publish its earnings?

Atreca publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Atreca?

The profits of Atreca are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Atreca?

You can learn more about the earnings of Atreca by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Atreca pay?

Over the past 12 months, Atreca paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Atreca is expected to pay a dividend of 0 USD.

What is the dividend yield of Atreca?

The current dividend yield of Atreca is .

When does Atreca pay dividends?

Atreca pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Atreca?

Atreca paid dividends every year for the past 0 years.

What is the dividend of Atreca?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Atreca located?

Atreca is assigned to the 'Health' sector.

Wann musste ich die Aktien von Atreca kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Atreca from 11/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.

When did Atreca pay the last dividend?

The last dividend was paid out on 11/9/2024.

What was the dividend of Atreca in the year 2023?

In the year 2023, Atreca distributed 0 USD as dividends.

In which currency does Atreca pay out the dividend?

The dividends of Atreca are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Atreca

Our stock analysis for Atreca Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Atreca Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.